IRIS
CICCIA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.414
NA - Nord America 1.759
AS - Asia 641
SA - Sud America 26
AF - Africa 3
Totale 4.843
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.750
IE - Irlanda 1.290
GB - Regno Unito 382
CN - Cina 297
SG - Singapore 258
IT - Italia 200
DE - Germania 174
GR - Grecia 172
FR - Francia 48
SE - Svezia 43
KR - Corea 42
FI - Finlandia 27
UA - Ucraina 20
BR - Brasile 18
BE - Belgio 17
IN - India 16
TR - Turchia 14
CZ - Repubblica Ceca 9
CA - Canada 8
CH - Svizzera 6
CO - Colombia 5
HK - Hong Kong 5
NL - Olanda 5
RS - Serbia 5
ES - Italia 4
JP - Giappone 4
RU - Federazione Russa 4
CL - Cile 3
EG - Egitto 3
PL - Polonia 3
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
BY - Bielorussia 1
GL - Groenlandia 1
IR - Iran 1
KZ - Kazakistan 1
TH - Thailandia 1
Totale 4.843
Salva come PNG Salva come JPEG
Città #
Dublin 1.290
Jacksonville 397
Princeton 187
Roxbury 187
Chandler 176
Singapore 143
Medford 140
Bremen 121
Beijing 72
Des Moines 61
Ann Arbor 51
Cambridge 50
Boardman 47
New York 46
Seoul 41
Wilmington 41
Jinan 33
Naples 29
Nanjing 24
Dearborn 20
Hefei 20
Hebei 16
Caserta 14
Brussels 13
Lappeenranta 12
Shenyang 12
Ashburn 11
Guangzhou 11
Helsinki 11
Norwalk 11
Redwood City 10
Brno 9
Nanchang 8
London 7
Munich 7
Ningbo 7
Palermo 7
Pune 7
Rome 7
Taiyuan 7
Berlin 6
Changsha 6
Kunming 6
Los Angeles 6
Shanghai 6
Tianjin 6
Bagnoli Irpino 5
Boston 5
Hangzhou 5
Houston 5
Ottawa 5
Vicenza 5
Bogotá 4
Groningen 4
Hyderabad 4
Kostroma 4
Milan 4
Mugnano di Napoli 4
San Severo 4
Wanchai 4
Woodbridge 4
Atlanta 3
Campina Grande 3
El Segundo 3
Elora 3
Gunzenhausen 3
Haikou 3
Harlow 3
Jiaxing 3
Lanzhou 3
Marseille 3
Napoli 3
Sant'Angelo in Formis 3
Santiago 3
Saviano 3
Taizhou 3
Taranto 3
Villa Literno 3
Zhengzhou 3
Avellino 2
Baotou 2
Catania 2
Chisinau 2
Cortona 2
Council Bluffs 2
Curitiba 2
Frankfurt am Main 2
Fuzhou 2
Gent 2
Huamu 2
Knokke-heist 2
Kraków 2
Lausanne 2
Livry-gargan 2
Maddaloni 2
Minerbio 2
Modena 2
Monza 2
Nanning 2
Niscemi 2
Totale 3.561
Salva come PNG Salva come JPEG
Nome #
An intense physical rehabilitation programme determines pain relief and improves the global quality of life in patients with fibromyalgia 78
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 61
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 54
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 51
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 48
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-Associated spondyloarthritis 48
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 47
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis 47
IL-23 OVEREXPRESSION AS IMMUNOLOGICAL SIGNATURE OF SUBCLINICAL INTESTINAL INFLAMMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS 46
NKP44+NK cells are expanded and produce high amounts of IL-22 in the salivary glands of Sjrogen syndrome patients 44
CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis 42
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort 40
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease 39
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 38
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 38
Ankylosing spondylitis: an autoimmune or autoinflammatory disease? 37
Gut dysbiosis in Spondyloarthritis: Cause or effect? 37
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome 37
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 37
Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vgamma9/Vdelta2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis? 36
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 36
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 34
Autophagy in the pathogenesis of ankylosing spondylitis 34
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 34
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 34
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 34
Intestinal dysbiosis and innate immune responses in axial spondyloarthritis 33
Role of subclinical gut inflammation in the pathogenesis of spondyloarthritis 33
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 33
The level of soluble Granzyme A is elevated in the plasma and in the Vgamma9/Vdelta2 T cell culture supernatants of patients with active Behçet's disease 32
Cardiovascular disease in primary sjögren’s syndrome 32
AUTOPHAGY, BUT NOT THE UNFOLDED PROTEIN RESPONSE, REGULATES THE EXPRESSION OF IL-23 IN THEGUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND SUBCLINICAL GUT INFLAMMATION 31
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 31
An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab 31
ILC3 in Axial Spondyloarthritis: the Gut Angle 31
Intestinal Involvement in Kawasaki Disease 30
Successful intravenous immunoglobulin treatment for steroid-resistant eosinophilic enteritis in a patient with systemic lupus erythematosus 30
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity 30
T2-mapping of the sacroiliac joints at 1.5 Tesla: a feasibility and reproducibility study 30
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 29
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage 29
Gut inflammation in spondyloarthritis 29
Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients 29
Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease 28
Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease 28
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome 28
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 28
What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis? 28
Autophagy occurs in lymphocytes infiltrating Sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions 28
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 28
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 26
The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome 26
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 26
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 26
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 26
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis 26
DIASTOLIC DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF BLOCKING AGENTS 25
IVIG in APS pregnancy 25
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 25
Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis 25
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases 25
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 25
Inflammasome activation in Ankylosing Spondylitis is associated to gut dysbiosis 25
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 24
PERIPHERAL AND INTESTINAL CD4+CD25HIGH T REGULATORY CELLS ARE EXPANDED IN ANKYLOSING SPONDYLITIS PATIENTS 24
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 24
Sclerostin and antisclerostin antibody serum levels predict the presence of axial spondyloarthritis in patients with inflammatory bowel disease 24
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 24
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 24
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis 24
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 24
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 23
OVER-EXPRESSION OF HUMAN DEFENSIN 5 IN THE SUBCLINICALLY INFLAMED GUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS 23
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 23
The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis 23
Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion 23
Subclinical gut inflammation in ankylosing spondylitis 23
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis 23
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs 23
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 23
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 23
Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 23
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 22
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort 22
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 22
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis 22
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis 22
Pentoxifylline inhibits Vgamma9/Vdelta2 T lymphocyte activation of patients with active Behçets disease in vitro 22
Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis 22
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 22
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients 22
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis 22
Prevalence of headache in patients with Behçet's disease without overt neurological involvement 22
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis 22
The craniovertebral junction in rheumatoid arthritis: State of the art 22
Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis 22
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient 22
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 22
IL-34 contributes to the development of a pro-inflammatory microenvironmentin patients with Sjrogen's Syndrome 21
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies 21
Totale 3.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020431 0 0 12 6 28 32 216 51 20 19 34 13
2020/2021593 10 8 21 37 109 6 146 12 39 16 181 8
2021/20221.010 21 11 1 24 372 4 37 16 48 28 66 382
2022/20231.713 246 12 26 17 208 59 3 60 1.012 5 42 23
2023/20241.029 33 30 39 55 367 100 27 29 11 7 57 274
2024/202560 14 46 0 0 0 0 0 0 0 0 0 0
Totale 5.171